Q3 Lab Company Earnings Take a Hit
A decline in COVID-19 testing demand, along with a challenging economy, made for a difficult quarter for diagnostics companies.
A decline in COVID-19 testing demand, along with a challenging economy, made for a difficult quarter for diagnostics companies.
Though only seven transactions were announced or closed in November, two were billion-dollar deals.
M&A deals in the diagnostics industry have been lower in number, but higher in impact in recent months.
Increasing incidences of heart disease, as well as technological advances, will drive growth over the next eight to 10 years, reports say.
Video telehealth during the early period of the COVID-19 quarantine was actually highly effective in providing accurate diagnoses, research shows.